215 related articles for article (PubMed ID: 20380650)
1. Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551.
Fukuda S; Ohta T; Sakata S; Morinaga H; Ito M; Nakagawa Y; Tanaka M; Matsushita M
Diabetes Obes Metab; 2010 Apr; 12(4):299-306. PubMed ID: 20380650
[TBL] [Abstract][Full Text] [Related]
2. Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice.
Wang CD; Teng BS; He YM; Wu JS; Pan D; Pan LF; Zhang D; Fan ZH; Yang HJ; Zhou P
Br J Nutr; 2012 Dec; 108(11):2014-25. PubMed ID: 22453054
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B.
Wu Y; Ou-Yang JP; Wu K; Wang Y; Zhou YF; Wen CY
Acta Pharmacol Sin; 2005 Mar; 26(3):345-52. PubMed ID: 15715932
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity mice.
Ito M; Fukuda S; Sakata S; Morinaga H; Ohta T
J Diabetes Res; 2014; 2014():680348. PubMed ID: 24987707
[TBL] [Abstract][Full Text] [Related]
5. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes.
Kasibhatla B; Wos J; Peters KG
Curr Opin Investig Drugs; 2007 Oct; 8(10):805-13. PubMed ID: 17907056
[TBL] [Abstract][Full Text] [Related]
6. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
Liu G; Trevillyan JM
Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
[TBL] [Abstract][Full Text] [Related]
8. New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells.
Ottanà R; Maccari R; Amuso S; Wolber G; Schuster D; Herdlinger S; Manao G; Camici G; Paoli P
Eur J Med Chem; 2012 Apr; 50():332-43. PubMed ID: 22381357
[TBL] [Abstract][Full Text] [Related]
9. Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
Zhang YN; Zhang W; Hong D; Shi L; Shen Q; Li JY; Li J; Hu LH
Bioorg Med Chem; 2008 Sep; 16(18):8697-705. PubMed ID: 18707891
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
Koren S; Fantus IG
Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
[TBL] [Abstract][Full Text] [Related]
11. Bioguided isolation of (9Z)-octadec-9-enoic acid from Phellodendron amurense Rupr. and identification of fatty acids as PTP1B inhibitors.
Steinmann D; Baumgartner RR; Heiss EH; Bartenstein S; Atanasov AG; Dirsch VM; Ganzera M; Stuppner H
Planta Med; 2012 Feb; 78(3):219-24. PubMed ID: 22124950
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of triazole-linked beta-C-glycosyl dimers as inhibitors of PTP1B.
Lin L; Shen Q; Chen GR; Xie J
Bioorg Med Chem; 2008 Nov; 16(22):9757-63. PubMed ID: 18922697
[TBL] [Abstract][Full Text] [Related]
14. Dammaranes from Gynostemma pentaphyllum and synthesis of their derivatives as inhibitors of protein tyrosine phosphatase 1B.
Xu JQ; Shen Q; Li J; Hu LH
Bioorg Med Chem; 2010 Jun; 18(11):3934-9. PubMed ID: 20472439
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors.
Gupta S; Pandey G; Rahuja N; Srivastava AK; Saxena AK
Bioorg Med Chem Lett; 2010 Oct; 20(19):5732-4. PubMed ID: 20797859
[TBL] [Abstract][Full Text] [Related]
16. Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling.
Erbe DV; Klaman LD; Wilson DP; Wan ZK; Kirincich SJ; Will S; Xu X; Kung L; Wang S; Tam S; Lee J; Tobin JF
Diabetes Obes Metab; 2009 Jun; 11(6):579-88. PubMed ID: 19383031
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine phosphatase 1B inhibitors for diabetes.
Johnson TO; Ermolieff J; Jirousek MR
Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
[TBL] [Abstract][Full Text] [Related]
19. Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-A(y) mice.
Takada M; Sumi M; Maeda A; Watanabe F; Kamiya T; Ishii T; Nakano M; Akagawa M
Biochem Biophys Res Commun; 2012 Nov; 428(2):315-20. PubMed ID: 23085227
[TBL] [Abstract][Full Text] [Related]
20. Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice.
Maeda A; Kai K; Ishii M; Ishii T; Akagawa M
Mol Nutr Food Res; 2014 Jun; 58(6):1177-89. PubMed ID: 24668740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
